Search Results - "Talaga, Patrice"

Refine Results
  1. 1

    SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy by Kaminski, Rafal M., Matagne, Alain, Leclercq, Karine, Gillard, Michel, Michel, Philippe, Kenda, Benoit, Talaga, Patrice, Klitgaard, Henrik

    Published in Neuropharmacology (01-03-2008)
    “…SV2A, a synaptic vesicle protein, has been recently identified as a binding target for levetiracetam (Keppra ®). The specific mechanism by which SV2A binding…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Keynote review: Histamine H3 receptor antagonists reach out for the clinic by Celanire, Sylvain, Wijtmans, Maikel, Talaga, Patrice, Leurs, Rob, de Esch, Iwan J.P.

    Published in Drug discovery today (01-12-2005)
    “…Histamine receptors represent a tried and tested target for the treatments of various conditions including allergic responses, gastric ulcers and dyspepsia…”
    Get full text
    Journal Article
  7. 7

    Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-κB activation by Mortier, Jérémie, Frederick, Raphaël, Ganeff, Corinne, Remouchamps, Caroline, Talaga, Patrice, Pochet, Lionel, Wouters, Johan, Piette, Jacques, Dejardin, Emmanuel, Masereel, Bernard

    Published in Biochemical pharmacology (15-05-2010)
    “…Docking of a new inhibitor of TAK1 (IC 50 = 0.56 μM) and identification of potential interactions with the hinge region: In this work, we aimed to build a…”
    Get full text
    Journal Article
  8. 8

    Compound decomposition: a new drug discovery tool? by Talaga, Patrice

    Published in Drug discovery today (15-01-2004)
    “…Chemical decomposition reactions might represent an unexplored and exciting research tool potentially leading to the discovery of completely new molecular…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Alkyne–quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD by Starck, Jean-Philippe, Provins, Laurent, Christophe, Bernard, Gillard, Michel, Jadot, Sophie, Lo Brutto, Patrick, Quéré, Luc, Talaga, Patrice, Guyaux, Michel

    Published in Bioorganic & medicinal chemistry (15-04-2008)
    “…SAR around alkyne–quinuclidine derivatives allowed the discovery of highly potent muscarinic antagonists displaying interesting preferential slow off-rates…”
    Get full text
    Journal Article
  13. 13

    In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone: A novel permeability transition pore inhibitor by Fuks, Bruno, Talaga, Patrice, Huart, Catherine, Hénichart, Jean-Pierre, Bertrand, Karine, Grimée, Renée, Lorent, Geneviève

    Published in European journal of pharmacology (05-09-2005)
    “…Despite the increasing implication of the permeability transition pore (PTP) in the pathophysiology of neurodegenerative diseases, few selective PTP inhibitors…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Efficient and regioselective 4-amino-de-chlorination of 2,4,6-trichloropyrimidine with N-sodium carbamates by Zanda, Matteo, Talaga, Patrice, Wagner, Alain, Mioskowski, Charles

    Published in Tetrahedron letters (11-03-2000)
    “…4- N-Alkoxycarbonyl-2,6-dichloropyrimidines have been synthesized with good to excellent regioselectivity and yields from 2,4,6-trichloropyrimidine and…”
    Get full text
    Journal Article